{
    "2018-05-21": [
        [
            {
                "time": "",
                "original_text": "【华兰生物*全铭团队】四价流感疫苗生产现场核查合格，产品上市可期，推动公司业绩增长",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "生产现场核查",
                        "合格",
                        "产品上市",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "一周机构调研：机构扎堆调研北方华创等公司",
                "features": {
                    "keywords": [
                        "机构调研",
                        "北方华创"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "半导体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}